Some clinics test your hormone levels every few months and charge for it. Standard guidance says routine monitoring of estrogen levels is generally not needed. Both cannot be right, and the difference matters because it is one of the clearest places where menopause care is sold rather than provided.

Where we stand: Menova is an independent publication. We sell no tests and no consultations, we are not your doctor, and this is general education, not medical advice.

The short version

Hormone therapy is titrated against your symptoms, not against a blood level. For most women, routine measurement of estradiol on treatment is not recommended and does not change what is done next.

The reasons:

  • There is no target level. No single estradiol value defines adequate treatment. Women feel well at very different levels
  • The number moves. With gels and sprays, the result depends heavily on when you last applied it. With patches it is steadier but still variable
  • The symptom picture answers the question anyway. If your hot flashes have gone and you are sleeping, the dose is working, whatever the number says. If they have not, the dose needs changing, whatever the number says

Our guide to adjusting treatment is what to change when HRT isn't working.

When testing is genuinely useful

It is not never. Specific situations where levels are measured:

  • Poor absorption is suspected — full dose, applied properly, and no response at all. Measuring can confirm whether the estrogen is getting in
  • Unusually high doses, where levels may be checked for safety
  • Implants (pellets), where levels can accumulate and testing has a clearer role
  • Under 40, in premature ovarian insufficiency, where testing is part of diagnosis and sometimes of management — see early and surgical menopause
  • After a hysterectomy with ovaries retained, where there is no bleeding pattern to observe — see hysterectomy and menopause
  • Testosterone, where levels are monitored — before starting, and periodically after, to keep them within the female physiological range; see testosterone for women

Note the pattern: testing answers a specific question. It is not a routine service.

What a proper review does involve

Annual review is standard. It should cover:

  • Symptoms — what improved, what did not, what is new
  • Bleeding pattern, which is the most informative single thing on combined therapy; see bleeding on HRT
  • Side effects, and whether the progestogen suits you
  • Blood pressure — see blood pressure and menopause
  • Weight, or waist measurement
  • Whether you are up to date with breast and cervical screening — see HRT, mammograms and breast density
  • Whether the balance of risks and benefits has changed for you
  • How you are applying it, which is the most commonly missed cause of poor response; see getting HRT to actually absorb

That is a conversation and a blood pressure cuff, not a panel.

Tests worth having anyway — for different reasons

Not to monitor HRT, but because they matter in this decade and are frequently missed:

Our full list for the decade is health screening in your 50s.

Why some clinics test frequently

Worth naming plainly, because it costs women a lot of money.

A business model built on repeat testing has a reason to test. When a clinic sells you a panel every three months, adjusts your dose against it, and sells you the next panel, the testing is the product.

Signals to notice:

  • Testing is presented as essential rather than as answering a question
  • "Optimising" your levels to a target — a marketing frame rather than a clinical one
  • Panels bundled with a treatment plan from the same provider
  • Saliva or urine hormone testing. Not validated for guiding hormone therapy, and not recommended by menopause societies
  • A quiz that recommends the provider's own testing

That does not mean every clinic doing any testing is exploiting you. It means "why are we measuring this, and what will we do differently depending on the result?" is a fair question — and a good clinician will answer it easily. See how to tell good menopause information from bad.

Separate from monitoring, and equally common.

For women over 45, guidance generally advises against using FSH or estradiol to diagnose the transition, because levels swing day to day. Symptoms and pattern are the diagnosis.

So a clinic charging for a hormone panel to tell you that you are perimenopausal is selling you a test that guidance advises against. This is also how women get told "your bloods are normal, so it isn't menopause" — see was that my last period and what to do if your doctor says no.

AMH measures ovarian reserve for fertility purposes. It does not predict when your last period will be, despite being marketed that way.

What to do with a result you already have

If you have been given levels:

  • Ask what the result changes. If the answer is nothing, that is informative about the test
  • Ask when the sample was taken relative to your last dose, particularly on gel
  • Do not chase a number. Feeling well at a "low" level is not a problem to be fixed
  • Do not increase your dose to move a number, without symptoms driving it

What to say

"Is this test going to change what we do? I've read that routine estradiol monitoring generally isn't recommended and that dosing is guided by symptoms."

Polite, specific, and it separates a clinician answering a question from a service selling a panel.

And for the review that does matter:

"I'd like an annual review — symptoms, bleeding, blood pressure, and whether my screening is up to date."

Our free 30-day symptom tracker produces the symptom record that a review is actually based on, and the free printable visit prep sheet turns it into one page.

The free 2-minute Menova self-check gives you a baseline to compare against — no account, not a diagnosis, and your answers never leave your device.

Whatever else is going on, unexpected bleeding needs assessing rather than explaining away. Any bleeding after twelve months without periods, bleeding that is new or persistent on hormone therapy, or bleeding after sex should be assessed in person — see bleeding after menopause and bleeding on HRT.

This article is general education, not medical advice. Monitoring requirements differ by treatment type, dose and individual circumstances, and some situations do require testing. Follow the plan agreed with your prescribing clinician.

Sources: NICE NG23 — Menopause, The Menopause Society, ACOG — The Menopause Years, and NHS — HRT.